Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Immunotec T-Spot Discovery SARS-CoV-2 RUO Kit

Oxford Immunotec Global has launched the T-Spot Discovery SARS-CoV-2 test kit for research use only. The kit builds on its experience with tuberculosis diagnosis and the assessment of the immune response to cytomegalovirus infections in transplant patients. Using the company's established T-Spot technology, the kit interrogates the immune system's T-cell response and will enable research into the measurement of the strength of that response to SARS-CoV-2, Oxford Immunotec said.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.